Norroy Bioscience
Norroy Bioscience, a leading name in the biotechnology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2015, the company has rapidly established itself as a key player in the development of innovative biopharmaceuticals and advanced diagnostic solutions. Specialising in cutting-edge gene editing and synthetic biology, Norroy Bioscience offers unique products that enhance research capabilities and therapeutic applications. Their commitment to quality and innovation has positioned them favourably in the competitive biotech landscape, earning recognition for their contributions to personalised medicine and disease management. With a focus on sustainability and scientific excellence, Norroy Bioscience continues to push the boundaries of biotechnology, striving to improve health outcomes globally. Their notable achievements reflect a dedication to advancing the industry while addressing critical healthcare challenges.
DitchCarbon Score
How does Norroy Bioscience's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Norroy Bioscience's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Norroy Bioscience's reported carbon emissions
Norroy Bioscience, headquartered in CN, currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3. Additionally, the company has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi), nor have they made any climate pledges. In the absence of specific emissions data or reduction initiatives, it is essential to note that many companies in the bioscience sector are increasingly focusing on sustainability and carbon neutrality. Norroy Bioscience may be exploring similar pathways to enhance their environmental impact in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Norroy Bioscience is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
